RAPT Therapeutics Announces Two FLX475 Presentations at the

SOUTH SAN FRANCISCO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies

Related Keywords

San Diego , California , United States , San Diego Convention Center , Aljanae Reynolds , Sylvia Wheeler , Society For Immunotherapy Of Cancer , Therapeutics Inc , Nasdaq , San Diego Convention , Region ,